Ganetespib as an inhibitor of heat shock protein 90 alleviates pulmonary fibrosis by inhibiting the Wnt/β-catenin signaling pathway.

Pulmonary fibrosis, a progressive interstitial lung disease with rising global incidence, currently has limited therapeutic options. Ganetespib is a potent HSP90 inhibitor, has shown anti-fibrotic potential in liver models, but its mechanism in pulmo…

Preview only. Read the full abstract at the source